Olaparib for Metastatic Castration-Resistant Prostate Cancer. Reply
N Engl J Med
.
2020 Aug 27;383(9):891.
doi: 10.1056/NEJMc2023199.
Authors
Johann de Bono
1
,
Jinyu Kang
2
,
Maha Hussain
3
Affiliations
1
Institute of Cancer Research, London, United Kingdom.
2
AstraZeneca, Gaithersburg, MD.
3
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
PMID:
32846073
DOI:
10.1056/NEJMc2023199
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Male
Phthalazines
Piperazines
Prostatic Neoplasms, Castration-Resistant*
Substances
Phthalazines
Piperazines
olaparib